A
Anthony M. Alleman
Researcher at University of Oklahoma Health Sciences Center
Publications - 21
Citations - 650
Anthony M. Alleman is an academic researcher from University of Oklahoma Health Sciences Center. The author has contributed to research in topics: Biopsy & Fine-needle aspiration. The author has an hindex of 9, co-authored 19 publications receiving 416 citations. Previous affiliations of Anthony M. Alleman include University of Oklahoma.
Papers
More filters
Journal ArticleDOI
Intermediate-risk meningioma: Initial outcomes from NRG Oncology RTOG 0539
Leland Rogers,Peixin Zhang,Michael A. Vogelbaum,Arie Perry,Lynn S. Ashby,Jignesh M. Modi,Anthony M. Alleman,James M. Galvin,David Brachman,Joseph M. Jenrette,John de Groot,Joseph Bovi,Maria Werner-Wasik,Jonathan P.S. Knisely,Minesh P. Mehta +14 more
TL;DR: The first clinical outcomes report from NRG Oncology RTOG 0539 supports the use of postoperative RT for newly diagnosed gross-totally resected WHO Grade II or recurrent WHO Grade I meningioma irrespective of resection extent and document minimal toxicity and high rates of tumor control with IMRT.
Journal ArticleDOI
High-risk Meningioma: Initial Outcomes From NRG Oncology/RTOG 0539.
C. Leland Rogers,Minhee Won,Michael A. Vogelbaum,Arie Perry,Lynn S. Ashby,Jignesh M. Modi,Anthony M. Alleman,James M. Galvin,Shannon Fogh,Emad Youssef,Nimisha Deb,Young Kwok,Clifford G. Robinson,Hui-Kuo Shu,Barbara Fisher,Valerie Panet-Raymond,William McMillan,John de Groot,Peixin Zhang,Minesh P. Mehta +19 more
TL;DR: The results of the initial analysis of the high-risk cohort of meningioma patients treated with intensity-modulated radiotherapy with IMRT support postoperative IMRT for high- risk patients, and invite ongoing investigations to further improve outcomes.
Journal ArticleDOI
Osmotic Demyelination Syndrome: Central Pontine Myelinolysis and Extrapontine Myelinolysis
TL;DR: Once thought to be universally devastating, ODS currently can have a variable clinical outcome.
Journal ArticleDOI
Microglia and a Functional Type I IFN Pathway Are Required To Counter HSV-1–Driven Brain Lateral Ventricle Enlargement and Encephalitis
Christopher D. Conrady,Min Zheng,Nico van Rooijen,Douglas A. Drevets,Derek J. Royer,Anthony M. Alleman,Daniel J.J. Carr +6 more
TL;DR: Using magnetic resonance imaging and type I IFN receptor–deficient mouse chimeras, it is demonstrated HSV-1 gains access to the murine brain stem and subsequently brain ependymal cells, leading to enlargement of the cerebral lateral ventricle and infection of the brain parenchyma in mice.
Journal ArticleDOI
Intermediate-Risk Meningioma: Initial Outcomes from NRG Oncology/RTOG-0539
L. Rogers,Peixin Zhang,Michael A. Vogelbaum,Arie Perry,Lynn S. Ashby,Jignesh M. Modi,Anthony M. Alleman,James M. Galvin,David Brachman,Joseph M. Jenrette,John DeGroot,Joseph Bovi,Maria Werner-Wasik,Jonathan P.S. Knisely,Minesh P. Mehta +14 more